Processing

Please wait...

Settings

Settings

Goto Application

1. WO2010052013 - TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

Publication Number WO/2010/052013
Publication Date 14.05.2010
International Application No. PCT/EP2009/007969
International Filing Date 06.11.2009
IPC
C07K 16/28 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
C07K 16/46 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
46Hybrid immunoglobulins
CPC
A61K 2039/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
505comprising antibodies
A61K 39/395
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61P 35/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
02specific for leukemia
C07K 16/2803
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
2803against the immunoglobulin superfamily
C07K 16/2809
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
2803against the immunoglobulin superfamily
2809against the T-cell receptor (TcR)-CD3 complex
Applicants
  • MICROMET AG [DE]/[DE] (AllExceptUS)
  • ZUGMAIER, Gerhard [DE]/[DE] (UsOnly)
Inventors
  • ZUGMAIER, Gerhard
Agents
  • MEIER, Jürgen
Priority Data
61/112,32307.11.2008US
61/183,29102.06.2009US
61/221,26929.06.2009US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
(FR) NOUVEAU TRAITEMENT DE LA LEUCÉMIE LYMPHOBLASTIQUE AIGUË DE L’ENFANT ET DE L’ADOLESCENT
Abstract
(EN) The present invention relates to a method for the treatment, amelioration or elimination of pediatric acute lymphoblastic leukemia (ALL), the method comprising the administration of a pharmaceutical composition comprising a CD19xCD3 bispecific single chain antibody construct to a pediatric ALL patient in the need thereof.
(FR) Méthode permettant de traiter, d’améliorer ou de guérir une leucémie lymphoblastique aiguë (LLA) de l’enfant et de l’adolescent, qui consiste à administrer une composition pharmaceutiques content une construction d’anticorps bispécifique à chaîne unique CD19xCD3 à un patient atteint de LLA qui en a besoin.
Related patent documents
RU2011122827This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau